365 related articles for article (PubMed ID: 8664716)
1. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction.
French JK; Williams BF; Hart HH; Wyatt S; Poole JE; Ingram C; Ellis CJ; Williams MG; White HD
BMJ; 1996 Jun; 312(7047):1637-41. PubMed ID: 8664716
[TBL] [Abstract][Full Text] [Related]
2. High mortality with ST elevation myocardial infarction in a nontrial setting.
Shufelt KA; Paradiso-Hardy FL; Papastergiou J; Cohen EA
Can J Cardiol; 2004 Dec; 20(14):1455-9. PubMed ID: 15614341
[TBL] [Abstract][Full Text] [Related]
3. Thrombolytic treatment for myocardial infarction: an examination of practice in 39 United Kingdom hospitals. Myocardial Infarction Audit Group.
Birkhead JS
Heart; 1997 Jul; 78(1):28-33. PubMed ID: 9290398
[TBL] [Abstract][Full Text] [Related]
4. Relationship of age with eligibility for thrombolytic therapy and mortality among patients with suspected acute myocardial infarction.
Krumholz HM; Friesinger GC; Cook EF; Lee TH; Rouan GW; Goldman L
J Am Geriatr Soc; 1994 Feb; 42(2):127-31. PubMed ID: 8126322
[TBL] [Abstract][Full Text] [Related]
5. [What thrombolytic rate can be realized in acute myocardial infarct? Results of the Oltner Heart Emergency Study].
Gaillet R; Saner H; Pfister R; Pirovino M
Schweiz Med Wochenschr; 1998 May; 128(20):775-83. PubMed ID: 9642753
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and outcome of patients with ST-elevation infarction in relation to whether they received thrombolysis or underwent acute coronary angiography: are we selecting the right patients for coronary angiography?
Herlitz J; Ekström L; Hartford M; Karlson BW; Karlsson T; Grip L
Clin Cardiol; 2003 Feb; 26(2):78-84. PubMed ID: 12625598
[TBL] [Abstract][Full Text] [Related]
7. A community survey of the potential use of thrombolytic agents for acute myocardial infarction.
Eisenberg MS; Ho MT; Schaeffer S; Litwin P; Larsen MP; Hallstrom AP; Weaver DW
Ann Emerg Med; 1989 Aug; 18(8):838-41. PubMed ID: 2757280
[TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction.
Krumholz HM; Murillo JE; Chen J; Vaccarino V; Radford MJ; Ellerbeck EF; Wang Y
JAMA; 1997 Jun; 277(21):1683-8. PubMed ID: 9169894
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy.
Cragg DR; Friedman HZ; Bonema JD; Jaiyesimi IA; Ramos RG; Timmis GC; O'Neill WW; Schreiber TL
Ann Intern Med; 1991 Aug; 115(3):173-7. PubMed ID: 2058871
[TBL] [Abstract][Full Text] [Related]
10. Thrombolysis in acute myocardial infarction. The implementation of thrombolytic therapy in a coronary care unit in 1992.
Haastrup B; Gill S; Haghfelt T
Cardiology; 1994; 85(6):397-406. PubMed ID: 7697675
[TBL] [Abstract][Full Text] [Related]
11. Selection of patients with acute myocardial infarction for thrombolytic therapy.
Muller DW; Topol EJ
Ann Intern Med; 1990 Dec; 113(12):949-60. PubMed ID: 2240919
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
[TBL] [Abstract][Full Text] [Related]
13. The risks of thrombolysis in patients without acute myocardial infarction.
Adams JN; Jamieson M; Trent RJ; Rawles J; Jennings KP
Int J Cardiol; 1995 Sep; 51(2):177-81. PubMed ID: 8522414
[TBL] [Abstract][Full Text] [Related]
14. Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis.
Grzybowski M; Clements EA; Parsons L; Welch R; Tintinalli AT; Ross MA; Zalenski RJ
JAMA; 2003 Oct; 290(14):1891-8. PubMed ID: 14532318
[TBL] [Abstract][Full Text] [Related]
15. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
16. [Are ECG criteria for indications for thrombolysis in acute myocardial infarct defined too narrowly?].
Weiss P; Sarasin C; Ritz R; Pfisterer M
Schweiz Med Wochenschr; 1991 Dec; 121(49):1829-32. PubMed ID: 1754866
[TBL] [Abstract][Full Text] [Related]
17. Eligibility for and benefit of thrombolytic therapy in inferior myocardial infarction: focus on the prognostic importance of right ventricular infarction.
Zehender M; Kasper W; Kauder E; Geibel A; Schönthaler M; Olschewski M; Just H
J Am Coll Cardiol; 1994 Aug; 24(2):362-9. PubMed ID: 8034869
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
[TBL] [Abstract][Full Text] [Related]
19. Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group.
Ketley D; Woods KL
Br Heart J; 1995 Sep; 74(3):224-8. PubMed ID: 7547014
[TBL] [Abstract][Full Text] [Related]
20. Interaction between arrival time and thrombolytic treatment in determining early outcome of acute myocardial infarction.
Wilkinson J; Foo K; Sekhri N; Cooper J; Suliman A; Ranjadayalan K; Timmis AD
Heart; 2002 Dec; 88(6):583-6. PubMed ID: 12433884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]